Why Humana Inc (HUM) Stock Is Rising
As of 2026-07-17, Humana Inc (HUM) has a next-year EPS growth estimate of 80.13%. Featured in 2 EPS revision reports, most recently on 2026-06-09.
Why HUM Stock Is Rising
- +EPS Estimate Upgraded: Analysts raised Humana Inc's next-year EPS growth estimate from 78.75% to 79.48% on 2026-07-13.
- →Estimate Trending Higher: Since detection, the estimate has moved up a net +0.65 pp to 80.13% across 1 upward revision.
- ·Current-Year Growth: Projected at -47.76%, supporting the forward estimate revision.
News Context
The primary structural driver of HUM's rise is the analyst upgrade on July 13, 2026, raising next-year EPS growth estimates from 78.75% to 80.13% across one upward revision. This upgrade likely ties to the announcement of Humana’s agreement to divest its minority interest in Gentiva for $900 million, which could support margin improvement and capital allocation. Momentum has continued, as the current EPS growth estimate now stands at 80
Generated 2026-07-17 · news as of 2026-07-17
Current Snapshot
- Sector
- Healthcare
- Industry
- Healthcare Plans
- EPS growth next year
- 80.13%
- EPS growth this year
- -47.76%
- EPS next quarter (est)
- $7.25
- Last price
- $400.00
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-07-17 | 80.13% | -47.76% | $7.25 | $400.00 |
| 2026-07-16 | 80.13% | -47.76% | $7.25 | $386.48 |
| 2026-07-15 | 80.13% | -47.76% | $7.25 | $407.78 |
| 2026-07-14 | 80.13% | -47.76% | $7.25 | $406.77 |
| 2026-07-13 | 79.48% | -48.29% | $7.23 | $406.00 |
| 2026-07-12 | 78.75% | -48.29% | $7.23 | $392.22 |
| 2026-07-09 | 78.75% | -48.29% | $7.23 | $397.76 |
| 2026-07-08 | 78.75% | -48.29% | $7.23 | $396.29 |
| 2026-07-07 | 78.75% | -48.29% | $7.23 | $394.62 |
| 2026-07-06 | 79.09% | -48.39% | $7.23 | $392.86 |
| 2026-07-05 | 79.09% | -48.39% | $7.23 | $396.75 |
| 2026-07-02 | 79.09% | -48.39% | $7.23 | $396.75 |
| 2026-07-01 | 79.09% | -48.39% | $7.23 | $409.42 |
| 2026-06-30 | 79.09% | -48.39% | $7.23 | $397.22 |
| 2026-06-29 | 79.09% | -48.39% | $7.23 | $388.90 |
| 2026-06-28 | 79.09% | -48.39% | $7.23 | $383.84 |
| 2026-06-25 | 79.09% | -48.39% | $7.23 | $376.00 |
| 2026-06-24 | 79.42% | -48.49% | $7.23 | $361.64 |
| 2026-06-23 | 79.42% | -48.49% | $7.23 | $359.13 |
| 2026-06-22 | 79.42% | -48.49% | $7.23 | $360.72 |
| 2026-06-21 | 79.42% | -48.49% | $7.23 | $360.65 |
| 2026-06-18 | 79.42% | -48.49% | $7.23 | $360.65 |
| 2026-06-17 | 79.42% | -48.49% | $7.23 | $362.00 |
| 2026-06-16 | 79.42% | -48.49% | $7.23 | $369.49 |
| 2026-06-15 | 79.42% | -48.49% | $7.23 | $380.26 |
| 2026-06-14 | 79.42% | -48.49% | $7.23 | $379.22 |
| 2026-06-11 | 79.42% | -48.49% | $7.23 | $368.69 |
| 2026-06-10 | 79.29% | -48.51% | $7.23 | $364.46 |
| 2026-06-09 | 79.29% | -48.51% | $7.23 | $363.18 |
| 2026-06-08 | 79.29% | -48.51% | $7.23 | $355.98 |
Reports Featuring HUM
Recent News
- The Premium On CVS Stock Vs What Its Peers DeliverTrefis
- The Premium On CVS Stock Vs What Its Peers DeliverTrefis
- American Express, Biogen upgraded: Wall Street's top analyst callsThe Fly
- UNH Showered Owners With Cash. The Stock Did Not CooperateTrefis
- Humana divests interest in end-of-life provider Gentiva valued at $900MHealthcare Dive
- Humana Announces Agreement to Divest Minority Interest in GentivaBusiness Wire
- Deutsche Bank sees new upswing for health insurers after years of margin pressureInvesting.com
- Trump's Portfolio Managers Traded UnitedHealth Ahead of Favorable Medicare Policy ChangeBarrons.com
- Many Retirees Find That Medicare Falls ShortBarrons.com
- Humana Invests More Than $1 Million to Advance Health Outcomes Across LouisianaBusiness Wire
Screen Performance
Aggregate stats across all 1864 tickers our top-EPS-revision screen has flagged over the past 107 days.
- Median return since detection
- +2.5%
- % of tickers in the green
- 55%
- Median return on winners
- +20.8%
- Large revisions captured
- 1048
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
Why did Humana Inc (HUM) stock go up recently?▾
Humana Inc (HUM) stock has risen following an analyst upgrade of its next-year EPS growth estimate from 78.75% to 79.48% on 2026-07-13. Since detection, the estimate has moved up a net +0.65 pp to 80.13%. EPS estimate upgrades are among the strongest leading indicators of stock outperformance.
What is Humana Inc's next-year EPS growth estimate?▾
As of 2026-07-17, Humana Inc (HUM) has a next-year EPS growth estimate of 80.13%, based on analyst consensus.
When was the latest EPS estimate revision for HUM?▾
The most recent revision occurred on 2026-07-14, when analysts adjusted the next-year EPS growth estimate from 79.48% to 80.13%.
What sector and industry does Humana Inc belong to?▾
Humana Inc operates in the Healthcare sector, specifically the Healthcare Plans industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. HUM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Humana Inc (HUM) appears here because it was detected by our daily top-EPS-revision-performer screen.